MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function.

Perlmutter Cancer Center at NYU Langone was 1 of 3 sites to take part in the Association of Cancer Care Centers quality ...

CARAMEL’ will work to deliver an innovative, AI-supported model for personalised cardiovascular risk assessment and preventive healthcare to address the urgent public health need for women ...

The practice of medicine has undergone an incredible, albeit incomplete, transformation over the past 50 years, moving ...

Blackheads, while harmless, remain a persistent skincare concern affecting people across all age groups. These small, dark ...

Modern tools for fluid management in patients on dialysis, including lung ultrasound and echocardiography, can help achieve ...

SHOPPING: Revolutionise your self-care routine with Nimbi's sustainable, women-designed razors that are kind to your skin and ...

L’Oréal's Cell BioPrint can give people precise data on how inflamed, aged, or dry their skin is prone to be, pointing them ...

The group’s Cell BioPrint device claims to tell users exactly what their complexion needs in ‘just five minutes’ using ...

Nurses, on the forefront of stroke care delivery, maintain a key role in early identification of patients ... Nurses should use a validated swallow screening tool as part of their ongoing assessment ...

In this last piece in our five-part series on the fundamental tools that should be in our self-care tool chests when we come from relational trauma backgrounds, we explore our final and possibly ...

Technological advances are improving the accuracy of skin cancer diagnosis and risk assessment. For example, researchers are investigating 3D total body skin imaging to monitor changes to spots ...